Latest news with #BharatSevaSansthan
Time of India
2 days ago
- Politics
- Time of India
Kakori Action recalled
Lucknow: The year 1922 in Indian struggle for Independence was marked by significant events that shaped the course of the freedom movement, one of the most notable being the Kakori Train Robbery, which, although occurred in 1925, was deeply rooted in revolutionary fervour reignited after suspension of the Non-Cooperation Movement in 1922. This was stated by renowned academicians during a national seminar at C B Gupta BSS College, Chandrawal, Lucknow, under joint auspices of Bharat Seva Sansthan and Motilal Memorial Society, to commemorate 100th anniversary of Kakori Action (1925-2025), on Saturday. Former head of Lucknow University's political science department Prof Ramesh Dixit said "1922 was a year of despair when Gandhi suspended Non-Cooperation Movement, prompting revolutionaries to loot the Kakori train and oppose British imperialism. " He said Ram Prasad Bismil and Ashfaqullah Khan worked gave shape to this plan. Kakori case, fought at the GPO (then a court), was remembered for sacrifices of Bismil, Ashfaqullah Khan, Rajendra Nath Lahiri and Thakur Roshan Singh, urging new generation to dedicate themselves to the nation with courage. TNN Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.
Hindustan Times
10-05-2025
- Health
- Hindustan Times
Ayurvedic study shows hope against cancer-causing HPV strains
A new Ayurvedic formulation developed to combat specific strains of the human papillomavirus (HPV) has shown promising results in an experimental study announced on Saturday. The research was unveiled during a press conference organised by Bharat Seva Sansthan, a social organisation, and endorsed by Prof JN Mishra, former dean and head of the faculty of Ayurveda, Lucknow University. HPV is a common virus that spreads mainly through sexual contact. According to prof Mishra, the study demonstrated strong anti-neoplastic and anti-HPV properties, particularly against HPV types 16 and 18, which are commonly associated with cervical cancer. 'The experimental study gave very fruitful results as very strong anti-neoplastic activity, and anti HPV virus activity, particularly HPV 16 and HPV 18 viruses, along with immuno-modulator agents,' he said. Mishra explained that the formulation showed the potential to inhibit the growth of cancer cells and limit the spread of HPV. In addition to targeting viral activity, it contains agents believed to stimulate the immune system, potentially aiding in the treatment of cancer and other infections. The experimental model was developed by a team of seven doctors and researchers led by Dr Ruchika Kaol Ghanekar, a senior scientist at the Cancer Research Lab, Pune. While the findings have been published in medical journals, the formulation is still in the experimental phase and is not yet being manufactured for clinical use. Further trials and regulatory approvals are likely to be required before it can be made available to patients.
